IGHE and allergic disease: Along these lines, accumulating evidence supports the role of microbiota-derived SCFAs in promoting tolerogenic immune responses in the healthy intestine and specifically affecting the MCs by direct inhibition of the IgE-mediated mast cell degranulation and allergen-induced histamine release, thus preventing the symptoms of allergic reaction (73).